Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT03539601
What this trial is testing

Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Who this might be right for
Atopic Dermatitis
Pfizer 237
Large-scale testing (Phase 3)Study completedNCT05375929
What this trial is testing

Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India

Who this might be right for
Atopic Dermatitis
Pfizer 200
Not applicableStudy completedNCT04174651
What this trial is testing

Stress-induced Scratching in Healthy and AD

Who this might be right for
HealthyAtopic Dermatitis
University of Miami 8
Not applicableActive Not RecruitingNCT03428646
What this trial is testing

Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 858
Not applicableActive Not RecruitingNCT05081557
What this trial is testing

Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 873
Not applicableUnknownNCT03962387
What this trial is testing

Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 98
Large-scale testing (Phase 3)Study completedNCT04417894
What this trial is testing

Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Who this might be right for
Moderate to Severe Atopic Hand and Foot Dermatitis
Regeneron Pharmaceuticals 133
Testing effectiveness (Phase 2)Looking for participantsNCT07297602
What this trial is testing

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

Who this might be right for
Atopic Dermatitis
Nora Mohamed Abdelrazik 36
Not applicableStudy completedNCT05682976
What this trial is testing

Ophthalmological Adverse Events of Tralokinumab in AD

Who this might be right for
Atopic Dermatitis
Nantes University Hospital 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07173478
What this trial is testing

Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Otsuka Pharmaceutical Co., Ltd. 156
Testing effectiveness (Phase 2)Study completedNCT04805411
What this trial is testing

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 120
Large-scale testing (Phase 3)Study completedNCT05608343
What this trial is testing

This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Acrotech Biopharma Inc. 153
Testing effectiveness (Phase 2)Ended earlyNCT05222516
What this trial is testing

Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

Who this might be right for
Atopic Dermatitis
OM Pharma SA 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT06727552
What this trial is testing

Barzolvolimab in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Celldex Therapeutics 131
Large-scale testing (Phase 3)Study completedNCT05372653
What this trial is testing

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Otsuka Pharmaceutical Co., Ltd. 41
Testing effectiveness (Phase 2)Looking for participantsNCT07298395
What this trial is testing

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Enveda Therapeutics 105
Testing effectiveness (Phase 2)Study completedNCT00932074
What this trial is testing

Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Kaken Pharmaceutical 58
Not applicableLooking for participantsNCT05938478
What this trial is testing

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

Who this might be right for
Atopic DermatitisEczema
University of California, San Diego 900
Large-scale testing (Phase 3)UnknownNCT05004324
What this trial is testing

Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Kang Stem Biotech Co., Ltd. 308
Large-scale testing (Phase 3)Study completedNCT02601703
What this trial is testing

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

Who this might be right for
Atopic Dermatitis
Glenmark Pharmaceuticals Ltd. India 1,110
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation